4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-024466
Chairman and CEO bought 17,300 shares at an average $1.68 ($29,021)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-04-13 | Purchase | +3,300 | $1.37 | $4,521 | 10,588,243 | D |
| Niihara Yutaka Chairman and CEO | 2020-04-14 | Purchase | +14,000 | $1.75 | $24,500 | 10,602,243 | D |
| Open-market purchases · 17,300 sh · avg $1.68 · $29,021 | |||||||
Loading xslF345X03/doc4.xml…